{"acute myeloid leukaemia": 9.83, "agranulocytosis": 3.23, "anaemia": 3.37, "anaphylactic reaction": 5.56, "anaphylactic shock": 8.69, "anaphylactoid reaction": 15.66, "aphthous ulcer": 3.0, "ascites": 2.63, "back pain": 5.09, "blister": 2.7, "breast cancer": 4.44, "breast cancer metastatic": 12.26, "bronchospasm": 16.27, "cardiac failure": 2.16, "cardiotoxicity": 25.16, "chest discomfort": 3.18, "cyanosis": 6.18, "dermatitis": 4.82, "dermatitis bullous": 11.94, "disease progression": 4.75, "dyspnoea": 2.62, "ejection fraction decreased": 7.16, "erythema": 6.86, "extravasation": 36.39, "face oedema": 2.18, "febrile neutropenia": 6.96, "feeling hot": 2.45, "flushing": 19.83, "haematotoxicity": 8.33, "hepatotoxicity": 2.88, "hot flush": 2.19, "hypersensitivity": 6.96, "hypotension": 3.06, "hypoxia": 3.26, "infusion related reaction": 58.48, "infusion site reaction": 33.65, "interstitial lung disease": 9.7, "intestinal obstruction": 4.36, "laryngeal oedema": 9.13, "leukopenia": 5.03, "liver injury": 2.67, "metastases to liver": 2.9, "mouth ulceration": 2.98, "mucosal inflammation": 20.87, "myelodysplastic syndrome": 2.99, "neoplasm progression": 2.68, "neutropenia": 7.13, "neutropenic sepsis": 8.43, "off label use": 4.8, "ovarian cancer": 55.65, "oxygen saturation decreased": 2.97, "palmar-plantar erythrodysaesthesia syndrome": 73.97, "pancytopenia": 5.28, "plasma cell myeloma": 4.5, "polyneuropathy": 2.75, "product use in unapproved indication": 15.48, "rash maculo-papular": 2.23, "respiratory distress": 2.16, "sense of oppression": 13.99, "sepsis": 2.39, "skin exfoliation": 5.63, "skin hyperpigmentation": 19.67, "skin lesion": 3.01, "skin reaction": 6.25, "skin toxicity": 25.0, "skin ulcer": 4.68, "stomatitis": 9.79, "throat tightness": 3.82, "thrombocytopenia": 3.87, "toxic epidermal necrolysis": 6.27, "toxic skin eruption": 17.33, "transaminases increased": 2.41}